title: Combined administration of hyperbaric oxygen and hydroxocobalamin improves cerebral metabolism after acute cyanide poisoning in rats.
abstract: Hyperbaric oxygen therapy (HBOT) or intravenous hydroxocobalamin (OHCob) both abolish cyanide (CN)-induced surges in interstitial brain lactate and glucose concentrations. HBOT has been shown to induce a delayed increase in whole blood CN concentrations, whereas OHCob may act as an intravascular CN scavenger. Additionally, HBOT may prevent respiratory distress and restore blood pressure during CN intoxication, an effect not seen with OHCob administration. In this report, we evaluated the combined effects of HBOT and OHCob on interstitial lactate, glucose, and glycerol concentrations as well as lactate-to-pyruvate ratio in rat brain by means of microdialysis during acute CN poisoning. Anesthetized rats were allocated to three groups: 1) vehicle (1.2 ml isotonic NaCl intra-arterially); 2) potassium CN (5.4 mg/kg intra-arterially); 3) potassium CN, OHCob (100 mg/kg intra-arterially) and subsequent HBOT (284 kPa in 90 min). OHCob and HBOT significantly attenuated the acute surges in interstitial cerebral lactate, glucose, and glycerol concentrations compared with the intoxicated rats given no treatment. Furthermore, the combined treatment resulted in consistent low lactate, glucose, and glycerol concentrations, as well as in low lactate-to-pyruvate ratios compared with CN intoxicated controls. In rats receiving OHCob and HBOT, respiration improved and cyanosis disappeared, with subsequent stabilization of mean arterial blood pressure. The present findings indicate that a combined administration of OHCob and HBOT has a beneficial and persistent effect on the cerebral metabolism during CN intoxication.
authors: Laboratory for Hyperbaric Medicine, Department of Anesthesia, Centre of Head and Orthopedics, Copenhagen University Hospital, Rigshospitalet, Denmark;
authors: M B
authors: MB
authors: Hansen
authors: N V
authors: NV
authors: Olsen
authors: O
authors: O
authors: Hyldegaard
mesh_terms: D000818:Animals; D062186:Arterial Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D005947:Glucose / Q000378:metabolism; D005990:Glycerol / Q000378:metabolism; D006879:Hydroxocobalamin / Q000008:administration & dosage*; D006931:Hyperbaric Oxygenation / Q000379:methods; D019344:Lactic Acid / Q000378:metabolism; D017551:Microdialysis / Q000379:methods; D010100:Oxygen / Q000008:administration & dosage*; D011190:Potassium Cyanide / Q000009:adverse effects*; D019289:Pyruvic Acid / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D019344:Lactic Acid; D019289:Pyruvic Acid; D005947:Glucose; D011190:Potassium Cyanide; D005990:Glycerol; D006879:Hydroxocobalamin; D010100:Oxygen
keywords: antidote; brain injury; cyanide; first aid; hyperoxia; intoxication; intracerebral microdialysis